Makers Laboratories LTD.
Makers Laboratories Ltd. (MAKERSL): company summary
The company's revenue grew 16.4% annually, but net profit fell 28.0% year-on-year.
Makers Laboratories Ltd. (MAKERSL) is a micro-cap Healthcare company valued at ₹123 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Makers Laboratories Ltd. last traded at ₹201.05, down 3.01% on the day.
- Recent developments
- On 2026-09-30, promoter holding remained at 61.27%, showing no significant change in ownership. The latest quarter results, ending 2026-06-30, showed a strong rebound in net profit, reflecting improved performance compared to the prior-year quarter.
- Financial performance
- The company's revenue grew 16.4% annually, but net profit fell 28.0% year-on-year. The latest quarter saw a sharp rise in net profit, up 256.6% compared to the same quarter a year earlier, while revenue rose 22.2%.
- Valuation multiples
- The stock trades at 50.4 times earnings, a premium to the Healthcare median of 32.0, 1.45 times book value.
- Things to watch
- Net profit margin narrowed 3.4 percentage points to 5.6%, indicating pressure on profitability. The stock is 11.8% below its 52-week high, suggesting a pullback from recent peak levels.
- Where it stands
- The company has shown strong growth in recent quarters, with net profit jumping 256.6% in the latest quarter. However, annual net profit fell 28.0%, and the net profit margin declined, signaling challenges in sustaining profitability. The stock is currently 11.8% below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (8.7) and momentum (6.3), but held back by valuation (0.0). Growth looks strong at 8.7, but that is offset by valuation at 0.0 and quality at 2.8. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Profit compounding 51% a year
- Low leverage — D/E 0.07
- Revenue compounding 15% a year
- Loss-making in some of the last 5 years
- Valuation is weak (0.0/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore MAKERS LABORATORIES LTD.’s valuation
Free deep-dive tools · no sign-up
MAKERS LABORATORIES LTD. peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare MAKERS LABORATORIES LTD. with peers
Related tools & concepts
Value MAKERS LABORATORIES LTD. with the ratios and calculators DocStoX uses in its analysis.

